Pain Severity in Flapless Dental Implant Placement Using Laser
- Conditions
- Jaw, Edentulous, Partially
- Interventions
- Device: Laser-induced IncisionProcedure: Punch IncisionProcedure: Implant Placement
- Registration Number
- NCT06294249
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
The goal of this split-mouth randomized clinical trial study was to investigate the effect of using a laser on pain and discomfort following flapless dental implant surgery. It was hypothesized that laser did not have any impact on post-op pain. Therefore, the study aimed to compare pain and discomfort following flapless dental implant surgeries with or without a laser.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- Adult human subjects agreed to participate in the study and return on follow-up times
- Subjects eligible for receiving dental implants
- Subjects with an edentulous area in the posterior of the mandible bilaterally 3- Subjects with sufficient bone width and height (>5 mm width, and >10 mm height) at the implant sites
- Subjects with sufficient keratinization tissue at the implant sites
- Subjects refused to return for follow-up or refused study enrollment.
- Subjects with uncontrolled systemic diseases
- Subjects younger than 18 years
- Subjects receiving psychotropic drugs
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Laser-induced Incision Laser-induced Incision The Biolase Epic 10 diode laser device (Biolase, USA) with 940 nm wavelength, 10 W of max output power, 20 KHz of pulse repetition rate, and continuous pulse mode was used. Punch Incision Implant Placement The soft tissue Osstem punch (South Korea) was used. Punch Incision Punch Incision The soft tissue Osstem punch (South Korea) was used. Laser-induced Incision Implant Placement The Biolase Epic 10 diode laser device (Biolase, USA) with 940 nm wavelength, 10 W of max output power, 20 KHz of pulse repetition rate, and continuous pulse mode was used.
- Primary Outcome Measures
Name Time Method Pain Severity Patients were visited at 24, 48, 72 hours, and 7 days after insertion. Measured using the visual analogue scale (VAS): 0-3 mild pain, 4-6 moderate pain, and 7-10 sever pain.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
shiraz University of medical sciences
🇮🇷Shiraz, Fars, Iran, Islamic Republic of